The Massachusetts Biotechnology Council

RSS

News & Press

MBC Applauds Passage of SBIR Reauthorization in US House of Representatives

Cambridge, MA

Wednesday

April 30, 2008

MBC Played Advocacy Role to Help Biotech Companies Become Eligible for Federal Grants Once Again

On Wednesday, April 23, the U.S House of Representatives voted overwhelmingly in favor of legislation that would once again let MBC member companies with venture capital funding compete for federal small business grants. The final tally was 369 - 43 in favor of Small Business Innovation Research (SBIR) Reauthorization. SBIR grants had been an essential source of early stage funding until 2003, when a Small Business Administration rules change barred some companies with venture backing from program participation. In last week's decision, eight of the ten House members from Massachusetts voted in favor of the MBC position rescinding that rules change and prohibition against venture capital backed firms.

Full Story

Massachusetts Life Sciences Initiative Legislation Clears Senate, Moves to Conference Committee

Cambridge

Wednesday

April 2, 2008

The Massachusetts Senate passed its version of the Life Sciences Initiative bill on Thursday, March 20th. The next step for the landmark Life Sciences legislation will be a review by a joint House-Senate conference committee, followed by a final report to both legislative bodies for final vote. To review both the House and senate versions of the bill, please follow the links below. You are also invited to review a "crosswalk" prepared by the MBC, which compares the two version of the legislation, side-by-side.

View the Life Sciences House bill, H. 4554, as amended.

View the Life Sciences Senate bill, S. 2566

View MBC's section-by-section summary of the bill.

Full Story

Massachusetts Biotechnology Council: Sustaining the Biotechnology Ecosystem

Cambridge

Monday

January 7, 2008

(article photo)

In the Message of Hope radio series, you hear real stories of three Massachusetts researchers and a clinical trials manager who work each day to produce cures for unmet medial needs. These talented individuals come from a cross-section of the Massachusetts Biotechnology Council Membership (MBC): an academic research institution, a small biotechnology company with 15 employees, a medium sized, public biotechnology company pushing for their first product, and a large biopharmaceutical company working on its next promising therapy.

Full Story

RSS

Recent Industry News

RSS

MBC In The Media

State Senate OKs Doctor Gift Ban: Boston Herald, April 19, 2008

Full Story

Takeda's $8.8B for Millennium includes bonuses for workers: Boston Herald, April 11, 2008

Full Story

Mass. biotech is sold for $8.8b - Japanese Drug Firm to run Millenium: Boston Globe, April 11, 2008

Full Story

Murray eyes Irish gold–Trade mission to push tourism, investment: Boston Herald, April 8, 2008

Full Story

Bristol-Myers job plans ahead of schedule in Devens: April 4, 2008

Full Story

Genzyme Will Expand Ireland plant, Add 170 Jobs; Boston Herald, April 2, 2008

Full Story

MBC Pushes Patent Reform, Biogeneric Drug Standard; Boston Business Journal, April 4, 2008

Full Story

Listen to Bob Coughlin, CEO of the Massachusetts Biotechnology Council, and John Maraganore, CEO of Alnylam Pharmaceuticals in an interview on Finneran's Forum on Boston's WRKO radio station.

Listen To The Podcast

View the Membership Directory

Events

View All...

Tue, May 20

The MBC Annual Meeting
Sheraton Boston Hotel

Tuesday, May 20, 2008
2:00pm - 7:00pm

Join us for a half-day comprehensive program to network, compare notes, learn about the latest industry trends, and share in the wisdom and expertise of your esteemed colleagues.

Biotechnology leaders will analyze tectonic shifts in healthcare that will impact business, science and policy. Explore featured panel presentations on the landscape for reimbursement of innovative therapeutics, the prospects for personalized medicine, and opportunities sparked by the state's soon-to-be-passed $1 billion Life Sciences Initiative.

Tue, June 3

Massachusetts Life Sciences Innovation Day 2008
Sheraton Boston Hotel

Massachusetts Life Sciences Innovation Day is an annual celebration of the research undertaken in Massachusetts and its contributions to the Commonwealth's life sciences industry and global healthcare. The day's program will look at the past, the present and the future. How have technologies in Massachusetts impacted our current life sciences industry? What technologies are currently emerging which have the potential to change the industry? And what are the major problems and questions in life sciences that our researchers should be focused on solving? The day's event will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies as well as the key life sciences funding sources including angels, foundations, venture capitalists, Federal Government and philanthropists.

Tue, June 17 – June 20

MBC Massachusetts Pavilion


Be a part of BIO2008. 
The BIO International Convention is the number one global event for the biotechnology industry.  It’s the largest annual gathering of the industry in the world with 22,633 attendees in 2007 and over 2, 200 exhibiting companies for 2008.

Exhibit in the MBC Massachusetts Pavilion:

  • One of the largest state pavilions
  • Individualized 10’ x 10’ booths
  • Collective presence on show floor
  • MBC marketing
  • Logo and link on MBC website
  • Visibility in BIO directory

Exhibit space is limited.  Join now!

Committees & Forums

View All...

Tue, May 13

"Role of Effective Planning in Project Success: Clinical Trial Start-up as a Case Study"

Project Management

Tue, May 13

"The Evaluation and Safe Handling of Potent Pharmaceutical Compounds"

Safety, Environmental and Facility Operations

Thu, May 15

"Technologies to build and select protein libraries"

Drug Discovery

Fri, May 16

Confronting Common Challenges in Managing Laboratory Data

Biostatistics/Data Management

Thu, May 29

"Drug & Device Law Update - Key Developments in Recent Case Law"

Law and Policy

Thu, May 29

Topics in Transdermal Drug Delivery

Formulation and Drug Delivery

Wed, June 4

Coaching the Generations: How to Motivate, Retain and Grow Today's Changing Workforce

Human Resources

Fri, June 6

State of the art and science associated with the use of statistical models used in the meta-analysis of clinical data.

Life Science Informatics

Tue, June 10

Data Integrity - The role and impact of Quality Assurance Compliance and Validation

Biostatistics/Data Management

Wed, June 11

QA Best Practices In A GLP Environment

Quality/Regulatory

Thu, June 12

Declining Productivity, Ever Increasing Cost and Lengthening Timelines for Pharmaceutical Innovation: Can India Provide a Solution?

Business Development